TABLE 1.
Baseline demographic and clinical characteristics.
| MBCT+TAU (n = 24) | TAU (n = 26) | P (Phi/T statistics) | |||
| Demographic characteristics | |||||
| Female gender | 13 | 54.2% | 16 | 61.5% | 0.28 (Phi = –0.075) |
| Age; M (SD) | 42.6 | 12.4 | 39.0 | 10.5 | 0.26 (T48 = –1.1) |
| Clinical characteristics | |||||
| Subtype of ADHD, DSM-IV | |||||
| Inattentive type | 13 | 54.2% | 16 | 61.5% | 0.87 (Phi = –0.28) |
| Hyperactive/impulsive type | 0 | 0% | 0 | 0% | |
| Combined type | 10 | 41.7% | 9 | 34.6% | |
| Not otherwise specified type | 1 | 4.2% | 1 | 3.8% | |
| ADHD symptoms (CAARS-INV) | |||||
| Subscales: | |||||
| Inattention | 16.9 | 5.2 | 18.6 | 3.8 | 0.20 (T48 = 1.3) |
| Hyperactive/impulsive | 11.7 | 6.5 | 14.2 | 5.9 | 0.15 (T48 = 1.5) |
| Total | 28.6 | 9.4 | 32.8 | 8.4 | 0.10 (T48 = 1.7) |
| Use of ADHD medication | 17 | 70.8% | 14 | 53.8% | 0.22 (Phi = 1.53) |